Zucara Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Zucara Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11053
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Zucara Therapeutics Inc (Zucara Therapeutics) is a pharmaceutical company that develops novel drug therapies to prevent hypoglycemia in people with diabetes. The company’s technology is used to prevent the dangerous low blood sugar by restoring the body’s ability to counter-regulate hypoglycemia. It is a commercialization agent for academic Institutions in Ontario, Canada. The company also offers therapies to rely of rescue therapies for glucose and glucagon. It works in partnerships with other organizations for the development of novel therapeutic approaches to prevent hypoglycemia. Zucara Therapeutics is headquartered in Vancouver, British Columbia, Canada.

Zucara Therapeutics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Zucara Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Zucara Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Zucara Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Zucara Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Zucara Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Zucara Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Zucara Therapeutics Raises USD3.9 Million in Financing 10
Zucara Therapeutics Raises USD0.4 Million in Venture Financing 11
Licensing Agreements 13
Zucara Therapeutics Enters into Licensing Agreement with Centre for Drug Research and Development 13
Zucara Therapeutics Inc – Key Competitors 14
Zucara Therapeutics Inc – Key Employees 15
Zucara Therapeutics Inc – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Corporate Communications 17
Sep 06, 2017: Zucara Therapeutics Appoints Luc Mainville as Board Chair 17
Jul 10, 2017: Dr. Claude Piche Joins Zucara’s Board of Directors 18
Product News 19
02/08/2018: Zucara Therapeutics Receives Funding to Advance Lead Drug Candidate 19
Clinical Trials 20
Sep 21, 2017: JDRF Funds Zucara Therapeutics’ Approach to Preventing Hypoglycemia in People with Type 1 Diabetes 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Zucara Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts 2
Zucara Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Zucara Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Zucara Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Zucara Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Zucara Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Zucara Therapeutics Raises USD3.9 Million in Financing 10
Zucara Therapeutics Raises USD0.4 Million in Venture Financing 11
Zucara Therapeutics Enters into Licensing Agreement with Centre for Drug Research and Development 13
Zucara Therapeutics Inc, Key Competitors 14
Zucara Therapeutics Inc, Key Employees 15
Zucara Therapeutics Inc, Other Locations 16

List of Figures
Zucara Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Zucara Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Zucara Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Zucara Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Zucara Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Zucara Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Zucara Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Zucara Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Zucara Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • QPS Austria GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary QPS Austria GmbH (QPS), a subsidiary of QPS Holdings LLC, is a contract research organization (CRO) which provides preclinical and clinical research services. The company offers in vivo services which include generating, characterizing and maintaining transgenic disease models and use them f …
  • Nayara Energy Ltd:企業の戦略的SWOT分析
    Nayara Energy Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Debiopharm Innovation Fund SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Debiopharm Innovation Fund SA (Debiopharm Innovation), formerly Debiopharm Diagnostics SA, a subsidiary of Debiopharm Group, is a patient care investment company that offers drug investments and development stage diagnostic solutions. The company offers investments for drugs on cancer severi …
  • Aero-Tech Engineering, Inc.:企業の戦略・SWOT・財務情報
    Aero-Tech Engineering, Inc. - Strategy, SWOT and Corporate Finance Report Summary Aero-Tech Engineering, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • China International Water & Electric Corp:企業の戦略的SWOT分析
    China International Water & Electric Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • GCL-Poly Energy Holdings Ltd:発電所・企業SWOT分析
    GCL-Poly Energy Holdings Ltd - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Memphasys Ltd (MEM)-医療機器分野:企業M&A・提携分析
    Summary Memphasys Ltd (Memphasys), formerly Nusep Holdings Ltd is a bio-separations company that develops and commercializes separation techniques based on its membrane technology. The company develops felix, a non-DNA damaging lab instrument for sperm separation that separates sperm from semen samp …
  • Owens & Minor Inc (OMI)-製薬・医療分野:企業M&A・提携分析
    Summary Owens & Minor Inc (Owens & Minor) is a healthcare services company, which provides supply chain services to healthcare providers and manufacturers of healthcare products. It provides logistics services for disposable medical supplies, devices and implants. Owens & Minor offers medical and su …
  • Revolution Lighting Technologies Inc (RVLT):企業の財務・戦略的SWOT分析
    Revolution Lighting Technologies Inc (RVLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • Ogeda SA-製薬・医療分野:企業M&A・提携分析
    Summary Ogeda SA (Ogeda), formerly Euroscreen SA is a biotechnology company that develops small molecule drugs targeting G-protein coupled receptors. The company discovers and develops drugs that treats hormone-dependent pathologies in women's health. It also develops drugs to treat neurodegenerativ …
  • Simplex Infrastructures Limited:戦略・SWOT・企業財務分析
    Simplex Infrastructures Limited - Strategy, SWOT and Corporate Finance Report Summary Simplex Infrastructures Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • SThree Plc (STHR):企業の財務・戦略的SWOT分析
    Summary SThree Plc (Sthree) is a staffing company that offers permanent and contract staffing business. The company operates through its sectors such as information and communications technology (ICT), energy, engineering, life sciences, banking and finance. Its business brands such as Computer Futu …
  • AGA Rangemaster Group Ltd:企業の戦略的SWOT分析
    AGA Rangemaster Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Empresas Publicas De Medellin ESP:企業の戦略的SWOT分析
    Empresas Publicas De Medellin ESP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Grupe SAB de CV:企業の戦略・SWOT・財務情報
    Grupe SAB de CV - Strategy, SWOT and Corporate Finance Report Summary Grupe SAB de CV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • PTC Inc.:企業の戦略・SWOT・財務情報
    PTC Inc. - Strategy, SWOT and Corporate Finance Report Summary PTC Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Gibson Energy Inc (GEI):企業の財務・戦略的SWOT分析
    Gibson Energy Inc (GEI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • AMAG Pharmaceuticals Inc:企業の戦略的SWOT分析
    AMAG Pharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Wienerberger AG:企業のM&A・事業提携・投資動向
    Wienerberger AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Wienerberger AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Johnson & Johnson (JNJ):企業の財務・戦略的SWOT分析
    Johnson & Johnson (JNJ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆